M. S. Schrock and K. Huebner, WWOX: a fragile tumor suppressor, Exp Biol Med (Maywood), vol.240, pp.296-304, 2015.

M. Abu-remaileh, E. J. Dodson, O. Schueler-furman, and R. I. Aqeilan, Pleiotropic functions of tumor suppressor WWOX in normal and cancer cells, J Biol Chem, vol.290, pp.30728-30763, 2015.

C. M. Aldaz, B. W. Ferguson, and M. C. Abba, WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies, Biochim Biophys Acta, vol.1846, pp.188-200, 2014.

M. Mallaret, M. Synofzik, J. Lee, C. A. Sagum, M. Mahajnah et al., The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation, Brain, vol.137, pp.411-420, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02434727

I. Baryla, E. Styczen-binkowska, and A. K. Bednarek, Alteration of WWOX in human cancer: a clinical view, Exp Biol Med (Maywood), vol.240, pp.305-319, 2015.

A. K. Bednarek, K. J. Laflin, R. L. Daniel, Q. Liao, K. A. Hawkins et al., WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer, Cancer Res, vol.60, pp.2140-2145, 2000.

K. Driouch, H. Prydz, R. Monese, H. Johansen, R. Lidereau et al., Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors, Oncogene, vol.21, pp.1832-1872, 2002.

C. J. Liu, W. G. Shen, S. Y. Peng, H. W. Cheng, S. Y. Kao et al., miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene, Int J Cancer, vol.134, pp.811-832, 2014.

H. W. Hua, F. Jiang, Q. Huang, Z. Liao, and G. Ding, MicroRNA-153 promotes Wnt/ beta-catenin activation in hepatocellular carcinoma through suppression of WWOX, Oncotarget, vol.6, pp.3840-3847, 2015.

A. K. Bednarek, C. L. Keck-waggoner, R. L. Daniel, K. J. Laflin, P. L. Bergsagel et al., WWOX, the FRA16D gene, behaves as a suppressor of tumor growth, Cancer Res, vol.61, pp.8068-73, 2001.

M. Fabbri, D. Iliopoulos, F. Trapasso, R. I. Aqeilan, A. Cimmino et al., WWOX gene restoration prevents lung cancer growth in vitro and in vivo, Proc Natl Acad Sci, vol.102, pp.15611-15617, 2005.

D. Iliopoulos, M. Fabbri, T. Druck, H. R. Qin, S. Y. Han et al., Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression, Clin Cancer Res, vol.13, pp.268-74, 2007.

H. R. Qin, D. Iliopoulos, S. Semba, M. Fabbri, T. Druck et al., A role for the WWOX gene in prostate cancer, Cancer Res, vol.66, pp.6477-81, 2006.

R. I. Aqeilan, F. Trapasso, S. Hussain, S. Costinean, D. Marshall et al., Targeted deletion of Wwox reveals a tumor suppressor function, Proc Natl Acad Sci, vol.104, pp.3949-54, 2007.

S. K. Abdeen, Z. Salah, B. Maly, Y. Smith, R. Tufail et al., Wwox inactivation enhances mammary tumorigenesis, Oncogene, vol.30, pp.3900-3906, 2011.

J. H. Ludes-meyers, H. Kil, M. I. Nunez, C. J. Conti, J. Parker-thornburg et al., WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy, Genes Chromosomes Cancer, vol.46, pp.1129-1165, 2007.

R. I. Aqeilan, J. P. Hagan, H. A. Aqeilan, F. Pichiorri, L. Y. Fong et al., Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo, Cancer Res, vol.67, pp.5606-5616, 2007.

K. Ried, M. Finnis, L. Hobson, M. Mangelsdorf, S. Dayan et al., Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells, Hum Mol Genet, vol.9, pp.1651-63, 2000.

J. H. Ludes-meyers, H. Kil, A. K. Bednarek, J. Drake, M. T. Bedford et al., WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins, Oncogene, vol.23, pp.5049-55, 2004.

M. Abu-odeh, T. Bar-mag, H. Huang, T. Kim, Z. Salah et al., Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks, J Biol Chem, vol.289, pp.8865-80, 2014.

Z. Salah, R. Aqeilan, and K. Huebner, WWOX gene and gene product: tumor suppression through specific protein interactions, Future Oncol, vol.6, pp.249-59, 2010.

N. Bouteille, K. Driouch, P. E. Hage, S. Sin, E. Formstecher et al., Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein, Oncogene, vol.28, pp.2569-80, 2009.

R. I. Aqeilan, Y. Pekarsky, J. J. Herrero, A. Palamarchuk, J. Letofsky et al., Functional association between Wwox tumor suppressor protein and p73, a p53 homolog, Proc Natl Acad Sci U S A, vol.101, pp.4401-4407, 2004.

M. Abu-odeh, Z. Salah, C. Herbel, T. G. Hofmann, and R. I. Aqeilan, WWOX, the common fragile site FRA16D gene product, regulates ATM activation and the DNA damage response, Proc Natl Acad Sci, vol.111, pp.4716-4741, 2014.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-74, 2011.

G. D. Eley, J. L. Reiter, A. Pandita, S. Park, R. B. Jenkins et al., A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma, Neuro-Oncology, vol.4, pp.86-94, 2002.

H. Masuda, D. Zhang, C. Bartholomeusz, H. Doihara, G. N. Hortobagyi et al., Role of epidermal growth factor receptor in breast cancer, Breast Cancer Res Treat, vol.136, pp.331-376, 2012.

C. Gao, M. Pang, Z. Zhou, S. Long, D. Dong et al., Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer, Clin Exp Med, vol.15, pp.469-75, 2014.

A. Baras, Y. Yu, M. Filtz, B. Kim, and C. A. Moskaluk, Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification, Oncogene, vol.28, pp.2919-2943, 2009.

A. Baras and C. A. Moskaluk, Intracellular localization of GASP/ECOP/VOPP1, J Mol Histol, vol.41, pp.153-64, 2010.

A. S. Baras, A. Solomon, R. Davidson, and C. A. Moskaluk, Loss of VOPP1 overexpression in squamous carcinoma cells induces apoptosis through oxidative cellular injury, Lab Investig, vol.9, pp.1170-80, 2011.

S. Park and C. D. James, ECop (EGFR-coamplified and overexpressed protein), a novel protein, regulates NF-kappaB transcriptional activity and associated apoptotic response in an IkappaBalpha-dependent manner, Oncogene, vol.24, pp.2495-502, 2005.

P. El-hage, A. Petitalot, A. H. Monsoro-burq, F. Maczkowiak, K. Driouch et al., The tumor-suppressor WWOX and HDAC3 inhibit the transcriptional activity of the beta-catenin coactivator BCL9-2 in breast cancer cells, Mol Cancer Res, vol.13, pp.902-914, 2015.

N. Nakamura, C. Rabouille, R. Watson, T. Nilsson, N. Hui et al., Characterization of a cis-Golgi matrix protein, GM130, J Cell Biol, vol.131, pp.1715-1741, 1995.

J. W. Chen, T. L. Murphy, M. C. Willingham, I. Pastan, and J. T. August, Identification of two lysosomal membrane glycoproteins, J Cell Biol, vol.101, pp.85-95, 1985.

M. C. Cheang, S. K. Chia, D. Voduc, D. Gao, S. Leung et al., Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer, J Natl Cancer Inst, vol.101, pp.736-50, 2009.

G. Eremo, A. Wegman, P. Stal, O. Nordenskjold, B. Fornander et al., Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients, Oncol Rep, vol.29, pp.1467-74, 2013.

R. I. Aqeilan, V. Donati, E. Gaudio, M. S. Nicoloso, M. Sundvall et al., Association of Wwox with ErbB4 in breast cancer, Cancer Res, vol.67, pp.9330-9336, 2007.

X. Wang, L. Chao, G. Ma, L. Chen, Y. Zang et al., The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype, J Cancer Res Clin Oncol, vol.137, pp.271-279, 2011.

C. Staudt, E. Puissant, and M. Boonen, Subcellular trafficking of mammalian lysosomal proteins: an extended view, Int J Mol Sci, vol.18, issue.1, p.47, 2017.

H. E. Eaton, G. Desrochers, S. B. Drory, J. Metcalf, A. Angers et al., SIMPLE/ LITAF expression induces the translocation of the ubiquitin ligase itch towards the lysosomal compartments, PLoS One, vol.6, p.16873, 2011.

M. Y. Li, F. J. Lai, L. J. Hsu, C. P. Lo, C. L. Cheng et al., Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats, PLoS One, vol.4, p.7820, 2009.

J. Fu, Z. Qu, P. Yan, C. Ishikawa, R. I. Aqeilan et al., The tumor suppressor gene WWOX links the canonical and noncanonical NF-kappaB pathways in HTLV-I Tax-mediated tumorigenesis, Blood, vol.117, pp.1652-61, 2011.

L. V. O'keefe, A. Colella, S. Dayan, Q. Chen, A. Choo et al., Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species, Hum Mol Genet, vol.20, pp.497-509, 2011.

M. Abu-remaileh and R. I. Aqeilan, The tumor suppressor WW domain-containing oxidoreductase modulates cell metabolism, Exp Biol Med (Maywood), vol.240, pp.345-50, 2015.

Q. W. Zheng, Y. L. Zhou, Q. J. You, F. Shou, Q. F. Pang et al., WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2, Cancer Gene Ther, vol.23, pp.433-441, 2016.

Y. Zhu, Y. Tian, J. Du, Z. Hu, L. Yang et al., Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration, PLoS One, vol.7, p.37823, 2012.

G. Natoli, A. Costanzo, F. Moretti, M. Fulco, C. Balsano et al., Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptorassociated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase, J Biol Chem, vol.272, pp.26079-82, 1997.

V. De-laurenzi, A. Costanzo, D. Barcaroli, A. Terrinoni, M. Falco et al., Two new p73 splice variants, gamma and delta, with different transcriptional activity, J Exp Med, vol.188, pp.1763-1771, 1998.

J. B. Sibarita, Deconvolution microscopy, Adv Biochem Eng Biotechnol, vol.95, pp.201-244, 2005.

F. Lallemand, S. R. Seo, N. Ferrand, M. Pessah, L. 'hoste et al., AIP4 restricts transforming growth factor-beta signaling through a ubiquitinationindependent mechanism, J Biol Chem, vol.280, pp.27645-53, 2005.

I. Bieche, B. Parfait, L. Doussal, V. Olivi, M. Rio et al., Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy, Cancer Res, vol.61, pp.1652-1660, 2001.

S. Sin, F. Bonin, V. Petit, D. Meseure, F. Lallemand et al., Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis, J Natl Cancer Inst, vol.103, pp.1323-1360, 2011.